EUVIMEDEUVIMED entdecken
EditorialKommentar

Do Digital Health Technologies Hold Promise for Preventing Progression to Type 2 Diabetes?

Tomoya Mita iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgae020 ↗

Kurz gefasst

Editorial in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Tomoya Mita. Beteiligte Einrichtung: Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Disease Progression. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Disease ProgressionHumansTelemedicineBiomedical TechnologyDigital TechnologyDigital Health

Stichwörter der Autor:innen

body weight reductioncontinuous glucose monitoringdigital health technologieslifestyle interventionpreventiontype 2 diabetes

Autor:innen und Institutionen

  • Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.

ORCID-Profile: Tomoya Mita

Zitieren

APA

Mita, T. (2024). Do Digital Health Technologies Hold Promise for Preventing Progression to Type 2 Diabetes?. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae020

Vancouver

Mita T. Do Digital Health Technologies Hold Promise for Preventing Progression to Type 2 Diabetes?. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae020

BibTeX
@article{Mita2024,
  author = {Mita, Tomoya},
  title = {Do Digital Health Technologies Hold Promise for Preventing Progression to Type 2 Diabetes?},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae020}
}
Kostenlos starten →